|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
Boston, Massachusetts 02135, US
|
|
Kineta completed a reverse merger with Yumanity Therapeutics with Kineta, Inc. as the surviving company effective December 19, 2022.
Revenue:$8M
|
Yumanity Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
100%
|
The widely used Yumanity Therapeutics email format is {f}{last} (e.g. [email protected]) with 100% adoption across the company.
To contact Yumanity Therapeutics customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.